
Lisa V. Cook
Examiner (ID: 13949, Phone: (571)272-0816 , Office: P/1678 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1641, 1642, 1678, 1677 |
| Total Applications | 1370 |
| Issued Applications | 805 |
| Pending Applications | 161 |
| Abandoned Applications | 418 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19355106
[patent_doc_number] => 12055541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-06
[patent_title] => System and sensor array
[patent_app_type] => utility
[patent_app_number] => 18/460221
[patent_app_country] => US
[patent_app_date] => 2023-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 143
[patent_figures_cnt] => 128
[patent_no_of_words] => 45436
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18460221
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/460221 | System and sensor array | Aug 31, 2023 | Issued |
Array
(
[id] => 18956558
[patent_doc_number] => 20240044885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => SYSTEM AND SENSOR ARRAY
[patent_app_type] => utility
[patent_app_number] => 18/460254
[patent_app_country] => US
[patent_app_date] => 2023-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18460254
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/460254 | SYSTEM AND SENSOR ARRAY | Aug 31, 2023 | Pending |
Array
(
[id] => 18809997
[patent_doc_number] => 20230384332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => RAPID ASSAY FOR APOL1 G0 PROTEIN
[patent_app_type] => utility
[patent_app_number] => 18/364663
[patent_app_country] => US
[patent_app_date] => 2023-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8483
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18364663
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/364663 | RAPID ASSAY FOR APOL1 G0 PROTEIN | Aug 2, 2023 | Pending |
Array
(
[id] => 18902779
[patent_doc_number] => 20240018264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTING AND TREATING OVARIAN CANCER
[patent_app_type] => utility
[patent_app_number] => 18/359380
[patent_app_country] => US
[patent_app_date] => 2023-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14234
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18359380
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/359380 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING OVARIAN CANCER | Jul 25, 2023 | Pending |
Array
(
[id] => 18860318
[patent_doc_number] => 20230414752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS
[patent_app_type] => utility
[patent_app_number] => 18/357013
[patent_app_country] => US
[patent_app_date] => 2023-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18357013
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/357013 | Constrained conditionally activated binding proteins | Jul 20, 2023 | Issued |
Array
(
[id] => 19140525
[patent_doc_number] => 20240139317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS
[patent_app_type] => utility
[patent_app_number] => 18/356985
[patent_app_country] => US
[patent_app_date] => 2023-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20748
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18356985
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/356985 | Constrained conditionally activated binding proteins | Jul 20, 2023 | Issued |
Array
(
[id] => 18956439
[patent_doc_number] => 20240044766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => NORMAL INCIDENT GUIDED-MODE-RESONANCE BIOSENSOR AND PROCALCITONIN DETECTION METHOD USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/355418
[patent_app_country] => US
[patent_app_date] => 2023-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18355418
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/355418 | NORMAL INCIDENT GUIDED-MODE-RESONANCE BIOSENSOR AND PROCALCITONIN DETECTION METHOD USING THE SAME | Jul 19, 2023 | Pending |
Array
(
[id] => 18770875
[patent_doc_number] => 20230365677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => CHECKPOINT BLOCKADE AND MICROSATELLITE INSTABILITY
[patent_app_type] => utility
[patent_app_number] => 18/224156
[patent_app_country] => US
[patent_app_date] => 2023-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18224156
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/224156 | CHECKPOINT BLOCKADE AND MICROSATELLITE INSTABILITY | Jul 19, 2023 | Pending |
Array
(
[id] => 19173785
[patent_doc_number] => 20240159759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => Early and Non Invasive Method for Assessing a Subject's Risk of Having Pancreatic Ductal Adenocarcinoma and Methods of Treatement of Such Disease
[patent_app_type] => utility
[patent_app_number] => 18/348398
[patent_app_country] => US
[patent_app_date] => 2023-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14223
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18348398
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/348398 | Early and non invasive method for assessing a subject's risk of having pancreatic ductal adenocarcinoma and methods of treatment of such disease | Jul 6, 2023 | Issued |
Array
(
[id] => 19159011
[patent_doc_number] => 20240151718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => CHIMERIC RECOMBINANT PROTEINS AND RECOMBINANT PROTEIN PANELS FOR THE DIAGNOSIS OF LYME DISEASE IN ANIMALS AND HUMANS
[patent_app_type] => utility
[patent_app_number] => 18/345563
[patent_app_country] => US
[patent_app_date] => 2023-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18345563
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/345563 | CHIMERIC RECOMBINANT PROTEINS AND RECOMBINANT PROTEIN PANELS FOR THE DIAGNOSIS OF LYME DISEASE IN ANIMALS AND HUMANS | Jun 29, 2023 | Pending |
Array
(
[id] => 20527313
[patent_doc_number] => 12545737
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-10
[patent_title] => Antibodies that bind to AXL proteins
[patent_app_type] => utility
[patent_app_number] => 18/344721
[patent_app_country] => US
[patent_app_date] => 2023-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 39
[patent_no_of_words] => 17233
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18344721
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/344721 | Antibodies that bind to AXL proteins | Jun 28, 2023 | Issued |
Array
(
[id] => 19097827
[patent_doc_number] => 20240117055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => ANTIBODIES THAT BIND TO AXL PROTEINS
[patent_app_type] => utility
[patent_app_number] => 18/344726
[patent_app_country] => US
[patent_app_date] => 2023-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18344726
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/344726 | Antibodies that bind to AXL proteins | Jun 28, 2023 | Issued |
Array
(
[id] => 20130135
[patent_doc_number] => 12372442
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => In situ heat induced antigen recovery and staining apparatus and method
[patent_app_type] => utility
[patent_app_number] => 18/329252
[patent_app_country] => US
[patent_app_date] => 2023-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 85
[patent_no_of_words] => 38860
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18329252
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/329252 | In situ heat induced antigen recovery and staining apparatus and method | Jun 4, 2023 | Issued |
Array
(
[id] => 18911299
[patent_doc_number] => 11874275
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Method for fluorescent immunoassay (FIA) and chemiluminescent immunoassay (CLIA) based on electrokinetic acceleration
[patent_app_type] => utility
[patent_app_number] => 18/205581
[patent_app_country] => US
[patent_app_date] => 2023-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8567
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18205581
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/205581 | Method for fluorescent immunoassay (FIA) and chemiluminescent immunoassay (CLIA) based on electrokinetic acceleration | Jun 4, 2023 | Issued |
Array
(
[id] => 19021324
[patent_doc_number] => 20240077495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => SPR-BASED BRIDGING ASSAY FORMAT FOR DETERMINING THE BIOLOGICAL ACTIVITY OF MULTIVALENT, MULTISPECIFIC MOLECULES
[patent_app_type] => utility
[patent_app_number] => 18/295739
[patent_app_country] => US
[patent_app_date] => 2023-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18295739
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/295739 | SPR-BASED BRIDGING ASSAY FORMAT FOR DETERMINING THE BIOLOGICAL ACTIVITY OF MULTIVALENT, MULTISPECIFIC MOLECULES | Apr 3, 2023 | Abandoned |
Array
(
[id] => 18740940
[patent_doc_number] => 20230349919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => Methods Of Mapping Antigen Specificity To Antibody-Secreting Cells
[patent_app_type] => utility
[patent_app_number] => 18/184054
[patent_app_country] => US
[patent_app_date] => 2023-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54281
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18184054
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/184054 | Methods Of Mapping Antigen Specificity To Antibody-Secreting Cells | Mar 14, 2023 | Pending |
Array
(
[id] => 18626720
[patent_doc_number] => 20230285526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => CANCER PREVENTION AND THERAPY BY INHIBITING SOLUBLE TUMOR NECROSIS FACTOR
[patent_app_type] => utility
[patent_app_number] => 18/182211
[patent_app_country] => US
[patent_app_date] => 2023-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18182211
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/182211 | Cancer prevention and therapy by inhibiting soluble tumor necrosis factor | Mar 9, 2023 | Issued |
Array
(
[id] => 20213579
[patent_doc_number] => 12410221
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Tumor antigens for determining cancer therapy
[patent_app_type] => utility
[patent_app_number] => 18/176283
[patent_app_country] => US
[patent_app_date] => 2023-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 22385
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18176283
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/176283 | Tumor antigens for determining cancer therapy | Feb 27, 2023 | Issued |
Array
(
[id] => 18628255
[patent_doc_number] => 20230287109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => VEGF and TIE2-Binding Fusion Protein and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/153965
[patent_app_country] => US
[patent_app_date] => 2023-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18153965
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/153965 | VEGF and TIE2-Binding Fusion Protein and Uses Thereof | Jan 11, 2023 | Pending |
Array
(
[id] => 20527535
[patent_doc_number] => 12545962
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-10
[patent_title] => Biomarker for predicting the prognosis of colorectal cancer
[patent_app_type] => utility
[patent_app_number] => 18/727602
[patent_app_country] => US
[patent_app_date] => 2023-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 55
[patent_no_of_words] => 3606
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18727602
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/727602 | Biomarker for predicting the prognosis of colorectal cancer | Jan 3, 2023 | Issued |